Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Addex Therapeutics

www.addextherapeutics.com

Latest From North China Pharmaceutical Group Corp.

Asia On The Move: Flurry Of Japan Appointments, Changes

The start of the fiscal second half in Japan in October brought a flurry of executive changes and reorganizations at foreign and domestic firms in the country including Allergan, Sandoz and Takeda.

Appointments Japan

Violations Uncovered At GSK, Pfizer Chinese Plants

Two recently released inspection results by western pharmaceutical regulatory authorities have put GlaxoSmithKline PLC and Pfizer Inc. in the spotlight after both multinationals ran into manufacturing problems in China.

Cancer Portugal

GMP issues, death reports hit Chinese hepatitis B vaccines

China is facing a serious shortage of recombinant hepatitis B vaccines because three major domestic manufacturers – Dalian-based Hissen, Shenzhen-based Bio Kangtai and Tiantan Biological Products of Beijing– officially halted production of their products on 1 January.

China

Orchid exits Chinese JV on 'flat' prospects but API exports to continue

Orchid Chemicals and Pharmaceuticals' recent exit from its 50:50 manufacturing joint venture in China does not imply that it is moving out of the Chinese market, the Indian company has affirmed. Orchid's plans are seen rather as part of the firm's strategy to consolidate manufacturing operations in India.

India
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Addex Pharmaceuticals Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Addex Therapeutics
  • Senior Management
  • Tim Dyer, CEO
    Roger G Mills, MD, CMO
    Sonia Poli, PhD, CSO & Head, Dev.
  • Contact Info
  • Addex Therapeutics
    Phone: (41) 22 884 1555
    12, chemin des Aulx
    Plan-les-Ouates, Geneva, 1228
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register